Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 8943 [2025-02186]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 22 / Tuesday, February 4, 2025 / Notices
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on December 2, 2024 (89 FR 95237).
DEPARTMENT OF JUSTICE
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
[FR Doc. 2025–02189 Filed 2–3–25; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
lotter on DSK11XQN23PROD with NOTICES1
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—America’s Datahub
Consortium
Notice is hereby given that, on
December 10, 2024, pursuant to section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
America’s DataHub Consortium
(‘‘ADC’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Optimal Solutions Group
LLC, College Park, MD; Radiance
Technologies, Huntsville, AL; Revelo
LLC, College Park, MD; and University
of Southern California, Los Angeles, CA,
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and ADC intends
to file additional written notifications
disclosing all changes in membership.
On November 11, 2021, ADC filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on December 22, 2021 (86 FR
72628).
The last notification was filed with
the Department on October 1, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on January 27, 2025 (90 FR 8223).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2025–02185 Filed 2–3–25; 8:45 am]
BILLING CODE 4410–11–P
VerDate Sep<11>2014
17:40 Feb 03, 2025
Jkt 265001
Antitrust Division
Notice is hereby given that, on
January 6, 2025, pursuant to section 6(a)
of the National Cooperative Research
and Production Act of 1993, 15 U.S.C.
4301 et seq. (‘‘the Act’’), Medical
Technology Enterprise Consortium
(‘‘MTEC’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, AccelerMED LLC,
Shoreview, MN; Aegir Enterprises LLC,
Jamul, CA; ANT5 Co., Ltd., Ube, JAPAN;
ARNAV Biotech, Atlanta, GA; Artery
Studios, Inc., Toronto, CANADA;
Astrapi Corp., Dallas, TX; Athena
Consulting Group LLC, North
Charleston, SC; Auxilium Health, Inc.,
Cleveland, OH; Berkeley Fit LLC, San
Diego, CA; Circuit Design Specialties,
Inc., Plano, TX; Clinical Research
Strategies LLC, Wexford, PA; Curavit
Clinical Research, Scarsdale, NY;
DatavizVR, Inc. dba 3Data, Austin, TX;
DesignPlex Biomedical LLC, Fort Worth,
TX; ECS Federal LLC, Fairfax, VA;
Evimero LLC, Tuscaloosa, AL; Exsurgo
Technologies LLC, Ashburn, VA;
Functional Longevity Labs, Inc., Easton,
MD; Green Immune LLC, Columbus,
GA; HereNow Help, Inc., Honeoye, NY;
Hermtac LLC, Dallas, TX; ICON
Government and Public Health
Solutions, Inc., Blue Bell, PA;
InflammaSense, Inc., Carlsbad, CA;
Institute for Evolvable Medicines,
Oakland, CA; Jaunt LLC, Mesa, AZ; Key
Technologies, Inc., Baltimore, MD;
Machina Medical, Inc., Roswell, GA;
Microbion Corp., Bozeman, MT; NCS
Technologies, Inc., Manassas, VA;
Neolixir, Ltd., Nedlands, AUSTRALIA;
NeuEsse, Inc., Dunbar, PA; Physical
Sciences, Inc., Andover, MA; POP
Biotechnologies, Inc., Buffalo, NY;
Qumulo, Inc., Seattle, WA; SightLine
Ventures, Dayton, OH; Songhi
Innovations, Fountain, CO; Teleflex,
Inc., Morrisville, NC; Texas Biomedical
Research Institute, San Antonio, TX;
The Neutrino Donut LLC, Culver City,
CA; University of Tennessee, Knoxville,
TN; University of Utah, Salt Lake City,
UT; Varada Consulting LLC, Vienna,
VA; and Zeteo Tech, Inc., Sykesville,
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
8943
MD have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and MTEC
intends to file additional written
notifications disclosing all changes in
membership.
On May 9, 2014, MTEC filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on June 9, 2014(79 FR 32999).
The last notification was filed with
the Department on October 7, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on December 20, 2024 (89 FR
104210).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2025–02186 Filed 2–3–25; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1121–0NEW]
Agency Information Collection
Activities: Proposed New Information
Collection Activity; Comment Request,
Proposed Study Entitled ‘‘National
Study of Interpersonal Violence
Experienced by Young Adults’’
National Institute of Justice,
U.S. Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Office of Justice Programs,
National Institute of Justice, is
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: The Department of Justice
encourages public comment and will
accept input until March 6, 2025
FOR FURTHER INFORMATION CONTACT: If
you have additional comments,
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Erica Howell, Social Science Research
Analyst, Office on Violence and
Victimization Prevention, by email at
erica.howell@usdoj.gov or telephone at
(202) 598–9431.
SUMMARY:
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 90, Number 22 (Tuesday, February 4, 2025)]
[Notices]
[Page 8943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-02186]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on January 6, 2025, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology
Enterprise Consortium (``MTEC'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. Specifically, AccelerMED LLC, Shoreview, MN; Aegir
Enterprises LLC, Jamul, CA; ANT5 Co., Ltd., Ube, JAPAN; ARNAV Biotech,
Atlanta, GA; Artery Studios, Inc., Toronto, CANADA; Astrapi Corp.,
Dallas, TX; Athena Consulting Group LLC, North Charleston, SC; Auxilium
Health, Inc., Cleveland, OH; Berkeley Fit LLC, San Diego, CA; Circuit
Design Specialties, Inc., Plano, TX; Clinical Research Strategies LLC,
Wexford, PA; Curavit Clinical Research, Scarsdale, NY; DatavizVR, Inc.
dba 3Data, Austin, TX; DesignPlex Biomedical LLC, Fort Worth, TX; ECS
Federal LLC, Fairfax, VA; Evimero LLC, Tuscaloosa, AL; Exsurgo
Technologies LLC, Ashburn, VA; Functional Longevity Labs, Inc., Easton,
MD; Green Immune LLC, Columbus, GA; HereNow Help, Inc., Honeoye, NY;
Hermtac LLC, Dallas, TX; ICON Government and Public Health Solutions,
Inc., Blue Bell, PA; InflammaSense, Inc., Carlsbad, CA; Institute for
Evolvable Medicines, Oakland, CA; Jaunt LLC, Mesa, AZ; Key
Technologies, Inc., Baltimore, MD; Machina Medical, Inc., Roswell, GA;
Microbion Corp., Bozeman, MT; NCS Technologies, Inc., Manassas, VA;
Neolixir, Ltd., Nedlands, AUSTRALIA; NeuEsse, Inc., Dunbar, PA;
Physical Sciences, Inc., Andover, MA; POP Biotechnologies, Inc.,
Buffalo, NY; Qumulo, Inc., Seattle, WA; SightLine Ventures, Dayton, OH;
Songhi Innovations, Fountain, CO; Teleflex, Inc., Morrisville, NC;
Texas Biomedical Research Institute, San Antonio, TX; The Neutrino
Donut LLC, Culver City, CA; University of Tennessee, Knoxville, TN;
University of Utah, Salt Lake City, UT; Varada Consulting LLC, Vienna,
VA; and Zeteo Tech, Inc., Sykesville, MD have been added as parties to
this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to section 6(b) of the Act on June 9,
2014(79 FR 32999).
The last notification was filed with the Department on October 7,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on December 20, 2024 (89 FR 104210).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2025-02186 Filed 2-3-25; 8:45 am]
BILLING CODE P
